381
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Previous pulmonary tuberculosis enhances the risk of lung cancer: systematic reviews and meta-analysis

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 255-268 | Received 26 Apr 2021, Accepted 11 Nov 2021, Published online: 22 Nov 2021

References

  • Woodman C, Vundu G, George A, et al. Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Semin Cancer Biol. 2021;69:349–364.
  • Corrales L, Rosell R, Cardona AF, et al. Lung cancer in never smokers: the role of different risk factors other than tobacco smoking. Crit Rev Oncol Hematol. 2020;148:102895.
  • Alencar Vtl D, Formiga MN, Lima Vcc D. Inherited lung cancer: a review. Ecancermedicalscience. 2020;14:1008.
  • Anttila S. Lung cancer: mechanisms and markers—carcinogens other than asbestos. Occupational cancers. Berlin: Springer; 2020. p. 257–272.
  • Nan L, Mu XL, Wang GL, et al. A genetic susceptibility study of lung cancer risk potentially associated with polycyclic aromatic hydrocarbon inhalation exposure. Biomed Environ Sci. 2017;30(10):772–776.
  • Szalontai K, Gémes N, Furák J, et al. Chronic obstructive pulmonary disease: epidemiology, biomarkers, and paving the way to lung cancer. J Clin Med. 2021;10(13):2889.
  • García JI, Mambuque E, Nguenha D, et al. Mortality and risk of tuberculosis among people living with HIV in whom TB was initially ruled out. Sci Rep. 2020;10(1):1–11.
  • Priftakis D, Riaz S, Zumla A, et al. Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in active and latent tuberculosis. Int J Infect Dis. 2020;92:S85–S90.
  • Tan ZM, Lai GP, Pandey M, et al. Novel approaches for the treatment of pulmonary tuberculosis. Pharmaceutics. 2020;12(12):1196.
  • Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020 [cited 2021 Feb 19]. Available from: https://apps​.who.int​/iris/bitstream/handle​/10665/336069/9789240013131-eng.pdf
  • Kiazyk S, Ball T. Tuberculosis (TB): latent tuberculosis infection: an overview. Can Commun Dis Rep. 2017;43(3–4):62–66.
  • Di Gennaro F, Vittozzi P, Gualano G, et al. Active pulmonary tuberculosis in elderly patients: a 2016–2019 retrospective analysis from an italian referral hospital. Antibiotics. 2020;9(8):489.
  • Control CfD, Prevention. TB elimination-the difference between latent TB infection and TB disease. Atlanta (GA): CDC; 2011.
  • Yi X, Zhang B, Fu Y, et al. STAT1 and its related molecules as potential biomarkers in Mycobacterium tuberculosis infection. J Cell Mol Med. 2020;24(5):2866–2878.
  • Rihawi A, Huang G, Al-Hajj A, et al. A case of tuberculosis and adenocarcinoma coexisting in the same lung lobe. Int J Mycobacteriol. 2016;5(1):80–82.
  • Cicėnas S, Vencevičius V. Lung cancer in patients with tuberculosis. World J Surg Onc. 2007;5(1):22.
  • Silva DR, Valentini DF, Müller AM, et al. Pulmonary tuberculosis and lung cancer: simultaneous and sequential occurrence. J Bras Pneumol. 2013;39(4):484–489.
  • Wu CY, Hu HY, Pu CY, et al. Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancer. 2011;117(3):618–624.
  • Bae JM, Li ZM, Shin MH, et al. Pulmonary tuberculosis and lung cancer risk in current smokers: the Seoul male cancer cohort study. J Korean Med Sci. 2013;28(6):896–900.
  • Liang HY, Li XL, Yu XS, et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009;125(12):2936–2944.
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Zhou Y, Deng X, Zang N, et al. Transcriptomic and proteomic investigation of HSP90A as a potential biomarker for HCC. Med Sci Monit. 2015;21:4039–4049.
  • Cummings P, Koepsell TD. On the need for the rare disease assumption in some case-control studies. Inj Prev. 2001;7(3):254–254.
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
  • Alavanja MC, Brownson RC, Boice Jr JD, et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol. 1992;136(6):623–632.
  • Brenner AV, Wang Z, Kleinerman RA, et al. Previous pulmonary diseases and risk of lung cancer in Gansu province, China. Int J Epidemiol. 2001;30(1):118–124.
  • Brenner DR, Hung RJ, Tsao MS, et al. Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. BMC Cancer. 2010;10(1):285.
  • Everatt R, Kuzmickiene I, Davidaviciene E, et al. Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania. Int J Tuberc Lung Dis. 2016;20(6):757–763.
  • Galeone C, Pelucchi C, La Vecchia C, et al. Indoor air pollution from solid fuel use, chronic lung diseases and lung cancer in harbin, northeast China. Eur J Cancer Prev. 2008;17(5):473–478.
  • Ko YC, Lee CH, Chen MJ, et al. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol. 1997;26(1):24–31.
  • Kreuzer M, Heinrich J, Kreienbrock L, et al. Risk factors for lung cancer among nonsmoking women. Int J Cancer. 2002;100(6):706–713.
  • Le CH, Ko YC, Cheng LS, et al. The heterogeneity in risk factors of lung cancer and the difference of histologic distribution between genders in Taiwan. Cancer Causes Control. 2001;12(4):289–300.
  • Liang H, Guan P, Yin Z, et al. Risk of lung cancer following nonmalignant respiratory conditions among nonsmoking women living in Shenyang, northeast China. J Womens Health (Larchmt). 2009;18(12):1989–1995.
  • Ramanakumar AV, Parent ME, Menzies D, et al. Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer. 2006;53(1):5–12.
  • Shiels MS, Albanes D, Virtamo J, et al. Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Prev Biomarkers. 2011;20:672–678.
  • Simonsen D, Farkas D, Søgaard M, et al. Tuberculosis and risk of cancer: a Danish nationwide cohort study. Int J Tuberc Lung Dis. 2014;18(10):1211–1219.
  • Wang XR, Ignatius T, Chiu YL, et al. Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control. 2009;20(5):757–763.
  • Wu AH, Fontham ET, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1995;141(11):1023–1032.
  • Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol. 2011;6(1):32–37.
  • Zatloukal P, An K, Pauk N, et al. Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer. 2003;41(3):283–293.
  • Zheng W, Blot W, Liao M, et al. Lung cancer and prior tuberculosis infection in shanghai. Br J Cancer. 1987;56(4):501–504.
  • Osann KE, Lowery JT, Schell MJ. Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer. 2000;28(1):1–10.
  • Gao YT, Blot WJ, Zheng W, et al. Lung cancer among chinese women. Int J Cancer. 1987;40(5):604–609.
  • Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol. 1999;149(1):13–20.
  • Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol. 1996;144(6):554–562.
  • Seow A, Poh WT, Teh M, et al. Diet, reproductive factors and lung cancer risk among chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer. 2002;97(3):365–371.
  • Bahraminia F, Zangiabadian M, Nasiri MJ, et al. Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-center study. New Microbes New Infect. 2021; 42:100909.
  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA A Cancer J Clin. 2021;71(1):7–33.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
  • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867.
  • Yu YY, Pinsky PF, Caporaso NE, et al. Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med. 2008;168(21):2326–2332.
  • Engels EA, Shen M, Chapman RS, et al. Tuberculosis and subsequent risk of lung cancer in xuanwei, China. Int J Cancer. 2009;124(5):1183–1187.
  • Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117(5):1175–1183.
  • Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res. 1994;54(7):1929s–1933s.
  • Nalbandian A, Yan B, Pichugin A, et al. Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. Oncogene. 2009;28(17):1928–1938.
  • Feld R, Bodey GP, Gröschel D. Mycobacteriosis in patients with malignant disease. Arch Int Med. 1976;136(1):67–70.
  • Libshitz HI, Pannu HK, Elting LS, et al. Tuberculosis in cancer patients: an update. J Thorac Imaging. 1997;12(1):41–46.
  • Petrella F, Casiraghi M, Prisciandaro E, et al. Incidental diagnosis of pulmonary mycobacteriosis among patients scheduled for lung cancer surgery: results from a series of 3224 consecutive operations. Heliyon. 2019;5(3):e01395.
  • Bhatt M, Kant S, Bhaskar R. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian J Cancer. 2012;1(1):36–42.
  • Korzeniewska-Koseła M, Gątarek J, Bestry I, et al. Tuberculosis diagnosed by thoracic surgeons. Polish Arch Int Med. 2021;131:633–642.
  • Rizzo SM, Kalra MK, Schmidt B, et al. CT images of abdomen and pelvis: effect of nonlinear three-dimensional optimized reconstruction algorithm on image quality and lesion characteristics. Radiology. 2005;237(1):309–315.
  • Dacosta N, Kinare S. Association of lung carcinoma and tuberculosis. J Postgrad Med. 1991;37(4):185–189.
  • Hwang IK, Paik SS, Lee SH. Impact of pulmonary tuberculosis on the EGFR mutational status and clinical outcome in patients with lung adenocarcinoma. Cancer Res Treat. 2018;51D:158–168.
  • Leung CY, Huang HL, Rahman MM, et al. Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates. BMC Cancer. 2020;20(1):1–13.
  • Wu-Williams AH, Dai XD, Blot W, et al. Lung cancer among women in North-east China. Br J Cancer. 1990;62(6):982–987.
  • Brownson RC, Alavanja MC. Previous lung disease and lung cancer risk among women (United States). Cancer Causes Control. 2000;11(9):853–858.
  • Kubı́k A, Zatloukal P, Boyle P, et al. A case-control study of lung cancer among czech women. Lung Cancer. 2001;31(2-3):111–122.
  • Lee CH, Ko YC, Goggins W, et al. Lifetime environmental exposure to tobacco smoke and primary lung cancer of non-smoking taiwanese women. Int J Epidemiol. 2000;29(2):224–231.
  • Kubı́k AK, Zatloukal P, Tomášek L, et al. Lung cancer risk among czech women: a case–control study. Prev Med. 2002;34(4):436–444.
  • Liu Q, Sasco AJ, Riboli E, et al. Indoor air pollution and lung cancer in guangzhou, people's republic of China. Am J Epidemiol. 1993;137(2):145–154.
  • Oh CM, Roh YH, Lim D, et al. Pulmonary tuberculosis is associated with elevated risk of lung cancer in korea: the nationwide cohort study. J Cancer. 2020;11(7):1899–1906.
  • Ho LJ, Yang HY, Chung CH, et al. Increased risk of secondary lung cancer in patients with tuberculosis: a nationwide, population-based cohort study. Plos One. 2021;16(5):e0250531.
  • Kim H, Kim HY, Goo JM, et al. Lung cancer CT screening and Lung-RADS in a tuberculosis-endemic country: the korean lung cancer screening project (K-LUCAS). Radiology. 2020;296(1):181–188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.